Results 141 to 150 of about 20,292 (247)

“Cholesterol-Years” for ASCVD Risk Prediction and Treatment

Journal of the American College of Cardiology, 2020
Michael D, Shapiro, Deepak L, Bhatt
openaire   +2 more sources

Correlation between ASCVD and cIMT <75^th percentile versus ≥75^th percentile.

, 2017
Correlation between ASCVD and cIMT th percentile versus ≥75th percentile.
Shahin Lockman (158491), Isaac Nkele (3779689), Tommy Palai (3779695), Mosepele Mosepele (355904), Kara Bennett (693422), Virginia A. Triant (2621152), Linda C. Hemphill (3779692)   +6 more
core   +1 more source

Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors:a cohort study

Background and aimsRandomized clinical trials of remnant cholesterol lowering drugs show 50 % and 80 % reduction in remnant cholesterol with apolipoprotein C3 (APOC3) and angiopoietin-like 3 (ANGPTL3) inhibitors.
Nordestgaard, Børge Grønne, Mortensen, Martin Bødtker, Afzal, Shoaib, Balling, Mie, Roepstorff, Otto Grøn, Gerds, Thomas Alexander, Langsted, Anne, Varbo, Anette   +7 more
core   +1 more source

The ASCVD Risk Estimator App

Journal of the American College of Cardiology, 2016
Gluckman, Ty J., Kovacs, Richard J., Stone, Neil J., Damalas, Dino, Mullen, J. Brendan, Oetgen, William J.   +5 more
openaire   +1 more source

Depression Risk and Outcomes Among ASCVD Patients [PDF]

Journal of General Internal Medicine, 2020
openaire   +4 more sources

An interpretable machine learning model with demographic variables and dietary patterns for ASCVD identification: from U.S. NHANES 1999–2018

Current research on the association between demographic variables and dietary patterns with atherosclerotic cardiovascular disease (ASCVD) is limited in breadth and depth.
Yan Luo, Qun Tang, Yong Wang
core   +1 more source

The correlation between exercise and atherosclerotic cardiovascular disease: a combined analysis using NHANES data (2007–2018) and Mendelian randomization

European Journal of Medical Research
Background Atherosclerotic Cardiovascular Disease (ASCVD) is a leading cause of death and disability worldwide, manifesting as myocardial infarction, stroke, and peripheral artery disease.
Zhao Zhao, Xintao Hu, Hongxu Yan, Chuangchuang Shen, Jichong Chen, Bing Wang   +5 more
doaj   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Biomarkers to Establish Low ASCVD Risk

Journal of the American College of Cardiology, 2020
John W. McEvoy, Chee H. Liew, Niall P. Connolly   +2 more
openaire   +1 more source